BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37467471)

  • 1. Opportunities Missed: Cervix Cancer Screening Failures in Women Aged 65 and Older.
    Ing BI; Scott ME; Lentz SE
    J Low Genit Tract Dis; 2023 Oct; 27(4):337-342. PubMed ID: 37467471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening.
    Kinney W; Sawaya GF; Sung HY; Kearney KA; Miller M; Hiatt RA
    Acta Cytol; 2003; 47(2):167-71. PubMed ID: 12685183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.
    Massad LS; Xie X; Minkoff HL; Michel KG; D'Souza G; Wang CC; Konkle-Parker D; Ofotokun I; Fischl MA; Rahangdale L; Strickler HD
    Am J Obstet Gynecol; 2021 Oct; 225(4):411.e1-411.e7. PubMed ID: 33957115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cytopathological changes in pregnancy: An experience from a low resource setting.
    Rasheed FA; Yakasai IA; Takai IU; Yusuf I; Ibrahim UM
    Ann Afr Med; 2021; 20(3):212-221. PubMed ID: 34558451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of Older Women With Cervical Cancer Based on Screening History.
    Clark M; Jembere N; Wang L; Kupets R
    J Low Genit Tract Dis; 2021 Jan; 25(1):9-14. PubMed ID: 33347044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
    Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
    J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
    Katki HA; Kinney WK; Fetterman B; Lorey T; Poitras NE; Cheung L; Demuth F; Schiffman M; Wacholder S; Castle PE
    Lancet Oncol; 2011 Jul; 12(7):663-72. PubMed ID: 21684207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program.
    Wang J; Elfström KM; Andrae B; Nordqvist Kleppe S; Ploner A; Lei J; Dillner J; Sundström K; Sparén P
    Int J Cancer; 2020 Mar; 146(5):1230-1240. PubMed ID: 31107987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. About invasive cervical cancer: a French population based study between 1998 and 2010.
    Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
    Nygård JF; Nygård M; Skare GB; Thoresen SØ
    Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
    Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
    PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.
    Whop LJ; Baade P; Garvey G; Cunningham J; Brotherton JM; Lokuge K; Valery PC; O'Connell DL; Canfell K; Diaz A; Roder D; Gertig DM; Moore SP; Condon JR
    PLoS One; 2016; 11(4):e0150473. PubMed ID: 27064273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening History Among Women with Invasive Cervical Cancer in an Academic Medical Center: Will We Miss Cancers Following Updated Guidelines?
    Nitschmann C; May T; Mirkovic J; Feldman S
    J Womens Health (Larchmt); 2016 Aug; 25(8):826-31. PubMed ID: 26859535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in Progression and Regression of Precancerous Lesions of the Uterine Cervix on Cytology Testing Among Women of Different Races.
    Martingano D; Renson A; Martingano AJ; Martingano FX
    J Am Osteopath Assoc; 2018 Jan; 118(1):8-18. PubMed ID: 29309102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix.
    Erzen M; Mozina A; Bertole J; Syrjänen K
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):185-91. PubMed ID: 11858896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
    Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
    J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening history and FIGO-stages among Danish women with cervical cancer in 2012-2014: a register-based study.
    Bchtawi AK; Saritas S; Schledermann D; Christensen RD; Jochumsen KM
    Sci Rep; 2019 Dec; 9(1):20390. PubMed ID: 31892698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.